The Latin America, Middle East and Africa Vitrification Market would witness market growth of 20.6% CAGR during the forecast period (2023-2030).
With the incorporation of vitrification technology, the research industry has also undergone a paradigm shift. Preserving delicate samples in their natural state is crucial to cryo-electron microscopy, a ground-breaking imaging technique that can map the atomic structure of biomolecules. This has dramatically improved the comprehension of intricate biological processes and disease causes.
The ongoing demand for better biological specimen storage and transportation is another factor propelling the market's expansion. Vitrification has been widely adopted in research institutions, biobanks, and medical facilities due to its advantages over conventional slow-freezing techniques, including decreased cell damage and improved post-thaw recovery rates.
Donor oocyte banks can now be established owing to the vitrification's outstanding efficiency. By preserving donor oocytes with particular characteristics, oocyte banking provides these oocytes to comprehensive recipient patients. As a result of not needing to coordinate donor and recipient cycles, it also gives egg recipient patients more flexibility and lowers the possibility of cycle cancellation.
The region of Latin America is renowned for its elite fertility hospitals and extensive fertility preservation programs. Brazilian reproductive medicine is well known for its cutting-edge methods and proficiency. Argentina is suitable for those thinking about egg freezing because of its friendly legal system, reasonable costs, and dedication to offering a wide range of reproductive options. With a focus on general wellness and cutting-edge medical technology, Costa Rica provides a comprehensive approach to fertility preservation. Reputable reproductive clinics in San Jose, the nation's capital, offer various services, like egg freezing. Considering all the elements, the regional market is expected to grow significantly.
The Brazil market dominated the LAMEA Vitrification Market, By Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $376.4 million by 2030. The Argentina market is showcasing a CAGR of 21.2% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 20.2% during (2023 - 2030).
Based on Specimen, the market is segmented into Oocytes (Devices, Kits & Consumables), Embryo (Devices, Kits & Consumables), and Sperm. Based on End-use, the market is segmented into IVF Clinics, and Biobanks. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Vitrolife AB, Genea Limited (Liverpool Partners Group), NidaCon International AB, Minitüb GmbH, Cryo Bio System (IMV Technologies Group), CooperSurgical Fertility & Genomic Solutions (The Cooper Companies, Inc.), FUJIFILM Irvine Scientific, Inc. (Fujifilm Holdings Corporation), Biotech, Inc., Kitazato Corporation and Shenzhen VitaVitro Biotech
With the incorporation of vitrification technology, the research industry has also undergone a paradigm shift. Preserving delicate samples in their natural state is crucial to cryo-electron microscopy, a ground-breaking imaging technique that can map the atomic structure of biomolecules. This has dramatically improved the comprehension of intricate biological processes and disease causes.
The ongoing demand for better biological specimen storage and transportation is another factor propelling the market's expansion. Vitrification has been widely adopted in research institutions, biobanks, and medical facilities due to its advantages over conventional slow-freezing techniques, including decreased cell damage and improved post-thaw recovery rates.
Donor oocyte banks can now be established owing to the vitrification's outstanding efficiency. By preserving donor oocytes with particular characteristics, oocyte banking provides these oocytes to comprehensive recipient patients. As a result of not needing to coordinate donor and recipient cycles, it also gives egg recipient patients more flexibility and lowers the possibility of cycle cancellation.
The region of Latin America is renowned for its elite fertility hospitals and extensive fertility preservation programs. Brazilian reproductive medicine is well known for its cutting-edge methods and proficiency. Argentina is suitable for those thinking about egg freezing because of its friendly legal system, reasonable costs, and dedication to offering a wide range of reproductive options. With a focus on general wellness and cutting-edge medical technology, Costa Rica provides a comprehensive approach to fertility preservation. Reputable reproductive clinics in San Jose, the nation's capital, offer various services, like egg freezing. Considering all the elements, the regional market is expected to grow significantly.
The Brazil market dominated the LAMEA Vitrification Market, By Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $376.4 million by 2030. The Argentina market is showcasing a CAGR of 21.2% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 20.2% during (2023 - 2030).
Based on Specimen, the market is segmented into Oocytes (Devices, Kits & Consumables), Embryo (Devices, Kits & Consumables), and Sperm. Based on End-use, the market is segmented into IVF Clinics, and Biobanks. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Vitrolife AB, Genea Limited (Liverpool Partners Group), NidaCon International AB, Minitüb GmbH, Cryo Bio System (IMV Technologies Group), CooperSurgical Fertility & Genomic Solutions (The Cooper Companies, Inc.), FUJIFILM Irvine Scientific, Inc. (Fujifilm Holdings Corporation), Biotech, Inc., Kitazato Corporation and Shenzhen VitaVitro Biotech
Scope of the Study
Market Segments Covered in the Report:
By Specimen- Oocytes
- Devices
- Kits & Consumables
- Embryo
- Devices
- Kits & Consumables
- Sperm
- IVF Clinics
- Biobanks
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Vitrolife AB
- Genea Limited (Liverpool Partners Group)
- NidaCon International AB
- Minitüb GmbH
- Cryo Bio System (IMV Technologies Group)
- CooperSurgical Fertility & Genomic Solutions (The Cooper Companies, Inc.)
- FUJIFILM Irvine Scientific, Inc. (Fujifilm Holdings Corporation)
- Biotech, Inc.
- Kitazato Corporation
- Shenzhen VitaVitro Biotech
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market At a Glance
Chapter 3. Market Overview
Chapter 4. LAMEA Vitrification Market, By Specimen
Chapter 5. LAMEA Vitrification Market, By End-use
Chapter 6. LAMEA Vitrification Market, By Country
Chapter 7. Company Profiles
Companies Mentioned
- Vitrolife AB
- Genea Limited (Liverpool Partners Group)
- NidaCon International AB
- Minitüb GmbH
- Cryo Bio System (IMV Technologies Group)
- CooperSurgical Fertility & Genomic Solutions (The Cooper Companies, Inc.)
- FUJIFILM Irvine Scientific, Inc. (Fujifilm Holdings Corporation)
- Biotech, Inc.
- Kitazato Corporation
- Shenzhen VitaVitro Biotech
Methodology
LOADING...
